Tuesday, May 20, 2014 6:57:35 PM
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
Date Filed # Docket Text
05/07/2014 69 MEMORANDUM in Support re 68 MOTION to Compel the Production of Documents and to Issue Sanctions filed by Securities and Exchange Commission. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Drabick, James) (Entered: 05/07/2014)
05/07/2014 68 MOTION to Compel the Production of Documents and to Issue Sanctions by Securities and Exchange Commission.(Drabick, James) (Entered: 05/07/2014)
05/02/2014 67 NOTICE re 51 Order Referring Case to ADR ISSUED, cc:cl. Magistrate Judge Kenneth P. Neiman is prepared to mediate this matter in Boston on 6/19/14. By no later than 5/14/14, the parties shall jointly inform the clerk by email (Bethaney_Healy@mad.uscourts.gov) as to (1) whether this matter is ripe for mediation, and (2) whether the proposed date is mutually convenient to the parties; cc/to Pro Se parties. (Healy, Bethaney) Modified on 5/5/2014 to add copy to pro se parties. (Finn, Mary). (Entered: 05/02/2014)
United States District Court
District of Massachusetts (Boston)
CIVIL DOCKET FOR CASE #: 1:12-cv-12334-WGY
Securities and Exchange Commission v. Spencer Pharmaceutical Inc et al
Assigned to: Judge William G. Young
Cause: 12:22 Securities Fraud
Date Filed: 12/17/2012
Jury Demand: Plaintiff
Nature of Suit: 850 Securities/Commodities
Jurisdiction: U.S. Government Plaintiff
Plaintiff
Securities and Exchange Commission
represented by Amy Gwiazda
United States Securities and Exchange Commission
33 Arch Street
23rd Flr.
Boston, MA 02110-1424
617-573-8839
Email: gwiazdaa@sec.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
James R. Drabick
Securities and Exchange Commission - MA
33 Arch Street
23rd Floor
Boston, MA 02110-1424
617-573-4535
Email: drabickj@sec.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Franklin C. Huntington , IV
Securities and Exchange Commission
33 Arch Street
23rd Floor
Boston, MA 02110
617-573-8960
Fax: 617-573-4590
Email: huntingtonf@sec.gov
ATTORNEY TO BE NOTICED
V.
Defendant
Spencer Pharmaceutical Inc
Defendant
Jean-Francois Amyot represented by Faun M. Phillipson
Phillipson & Uretsky LLP
111 Broadway
8th Floor
New York, NY 10006
212-571-1255
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Jonathan C. Uretsky
Phillipson & Uretsky LLP
111 Broadway
8th Floor
New York, NY 10006
212-571-1255
Email: uretsky@phillipson-uretsky.com
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Mitchell R. Edwards
Hinckley Allen Snyder LLP
Suite 1500
50 Kennedy Plaza
Providence, RI 02903
401-274-2000
Fax: 401-277-9600
Email: medwards@haslaw.com
ATTORNEY TO BE NOTICED
Defendant
Maximilien Arella represented by Maximilien Arella
586 Giraud
Laval, QC H7X 3J6
Canada
514-995-9874
PRO SE
Defendant
Ian Morrice represented by Ian Morrice
9 Okanagan Drive
Nepean, ON K2H 7E7
Canada
613-808-0542
PRO SE
Defendant
IAB Media Inc. represented by Faun M. Phillipson
(See above for address)
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Jonathan C. Uretsky
(See above for address)
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Mitchell R. Edwards
(See above for address)
ATTORNEY TO BE NOTICED
Defendant
Hilbroy Advisory Inc.
represented by Faun M. Phillipson
(See above for address)
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Jonathan C. Uretsky
(See above for address)
LEAD ATTORNEY
PRO HAC VICE
ATTORNEY TO BE NOTICED
Mitchell R. Edwards
(See above for address)
ATTORNEY TO BE NOTICED
Mediator
Judge Kenneth P. Neiman
https://ecf.mad.uscourts.gov/cgi-bin/iquery.pl
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM